http://www.otonomy.com
Otonomy, Inc. Company Intro
Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings of frustration, decreased social interaction and depression. At Otonomy, our focus is on making new treatments a reality for the millions living with the debilitating, daily impact of these conditions.
Industry
Healthcare
Otonomy, Inc. Headquaters
4796 Executive Drive
San Diego,92121
United States
Otonomy, Inc. Share price
14 Sep 2022 09:57 GMT
$0.3700
-0.0 (-0.83 %)
Otonomy, Inc. Market cap
$19.838 M
WMC RANKING
2022
Otonomy, Inc. # 278
BiotechnologyLatest Otonomy, Inc. News
30 Nov 2022
Recent Change of 74.79% in the Otonomy Inc. (OTIC) market ...
For the readers interested in the stock health of Otonomy Inc. (OTIC). It is currently valued at $0.19. When the transactions were called off in the...
30 Nov 2022
Is Otonomy Inc (OTIC) a Leader in the Healthcare Sector?
Otonomy Inc (OTIC) is near the top in its sector according to InvestorsObserver. OTIC gets an overall rating of 87. That means it scores higher than 87% of...
30 Nov 2022
Why Leslie's Shares Are Trading Lower By Over 9%? Here ...
Corbus Pharmaceuticals Holdings, Inc. ... shares surged 36.2% to $10.00 after the company reported Q3 earnings and delivery results and ... Otonomy, Inc.
WMC Market Score
WMC Market to Revenue Score
Otonomy, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Otonomy, Inc. | USD | $203 | $42,767 | $-45,178 | $198M | 278 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Otonomy, Inc. Social Followers vs Top 4 Industry Competitors
Otonomy, Inc. Post vs Top 4 Industry Competitors
Otonomy, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Otonomy, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Otonomy, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Otonomy, Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
